Market Analysis
The global Healthcare Mobility Solutions Market is anticipated to touch USD 105,000 million at a 25.0% CAGR between 2019-2025, states the latest Market Research Future (MRFR) report. Healthcare mobility includes the usage of enterprise platforms, applications, and mobile devices for communicating and efficiently and securely exchanging clinical data among different end users, including patients, providers, and payers. These solutions play a pivotal role in solving the major challenges that the industry faces, such as demand for superior quality healthcare, decreasing profitability, increasing error rates, fast-changing regulatory environment, and rising costs. Various factors are propelling the healthcare mobility solutions market growth. Such factors, according to the latest Market Research Future report, include rising adoption of connected healthcare devices, expansion in wireless network technology, increasing focus on patient-centered approach and personalized medicine, growing demand for point-of-care diagnosis treatment, increased awareness about the potential advantages of healthcare management, increasing influence of social media on healthcare, rising use of smart devices, and digitalization. On the contrary, scarcity of skilled professionals, data security concerns, quickly changing regulatory environment, rising technical error rates, cost and infrastructural issues, lack of reimbursement policies and standard communication protocols, and short battery life of mobile healthcare technology devices are factors that may impede the healthcare mobility solutions market growth during the forecast period. Request For Free Sample Copy : https://www.marketresearchfuture.com/sample_request/1970 Market Segmentation The Market Research Future report offers a complete segmental analysis of the healthcare mobility solutions market based on end user, application, and product and service. By product and service, the healthcare mobility solutions market is segmented into enterprise platform, health mobile devices, mobile applications, and others. The health mobile devices are again segmented into barcode scanners, RFID scanners, mobile computers, and others. Of these, the enterprise platform segment will lead the market during the forecast period. By application, the healthcare mobility solutions market is segmented into enterprise mobility management and mHealth. The mHealth segment is again segmented into women’s health medication management, weight loss, chronic care management, and others. The enterprise management segment is again segmented into workforce management, operations management, and patient care management. Of these, the mHealth segment will dominate the market during the forecast period. By end users, the global healthcare mobility solutions market is segmented into patients, laboratories, hospitals and clinics, and others. Of these, the hospital and clinic segment will have the maximum share in the market during the forecast period. Browse Complete Toc :https://www.marketresearchfuture.com/reports/healthcare-mobility-solutions-market-1970 Regional Analysis By region, the healthcare mobility solutions market report covers the latest trends and growth opportunities across Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will command the largest share in the market during the forecast period for the increasing healthcare expenditure coupled with the presence of a well-established healthcare sector. The healthcare mobility solutions market in Europe will have the second-largest share in the market during the forecast period. Various factors propelling the growth of healthcare mobility technology and services in the region include growing demand for efficient digital solutions to maintain electronic health records, offering medical education, and keeping track and managing patient’s health, technological advancements, and standard communication protocols. Germany is the major contributor in this region. The healthcare mobility solutions market in the APAC region will grow at the fastest pace during the forecast period. Various factors propelling the growth of healthcare mobility technology and services in the region include the increasing use of healthcare mobility devices, increasing government initiatives, presence of a huge patient pool, and rapid adoption of advanced digital healthcare devices. India, Japan, and China are the major contributors in this region. The healthcare mobility solutions market in the MEA will have a small share during the forecast period for the low economic development in the African region. Key Players Notable players profiled in the healthcare mobility solutions market report include [x]cube LABS, Zebra Technologies Corporation, Wipro Limited, SAP SE, Philips Healthcare, Oracle Corporation, Omron Corporation, Mckesson Corporation, Infosys Limited, FUTURA MOBILITY LLC, FuGenX Technologies, Codecube, Cisco Systems, Inc., Cerner Corporation, AtT, Inc., and Airstrip Technologies, Inc.
0 Comments
Overview:
The apheresis market is getting significant traction due to the growing emphasis on the specific features of blood that impacts researches and transfusion. It is a technology that purifies blood or separate components for a smoother after-study related to blood. It relies on centrifugation and membrane filtration technology. From the donor’s body, the apheresis machine can draw in blood and filter the required components based on the molecular size and weight. It has specific functions related to diseases such as neurological, cardiovascular, renal, autoimmune, hematological and others. The global apheresis market is expected to clock an impressive 10.2% CAGR during the forecast period (2017-2023), reveals Market Research Future (MRFR). The report encompasses segmental analysis and factors that can trigger market growth in the coming years. Among the major factors, growth in the number of registered cases regarding cancer has become impactful. In addition, blood transfusion plays an important role in several difficult surgical procedures which can provide traction to the market. Healthcare-related researches can also open up growth possibilities. On the flip side, the apheresis market can be restrained by the high-cost associated with it. At the same time, lack of skilled individuals is also impacting the market substantially by taking a dig at the CAGR during the forecast period. Request Free Sample: https://www.marketresearchfuture.com/sample_request/1508 Segmentation: The global apheresis market can be segmented by product, procedure, methods, application, and end-users. Based on the product, the apheresis market includes devices and disposables. The devices segment can be sub-segmented into platelets separators, plasma separators, and others. Procedure-wise, the apheresis market comprises leukapheresis, plateletpheresis, plasmapheresis, erythrocytapheresis, and others. Method-based segmentation of the apheresis market includes filtration and centrifugation. Centrifugation consists intermittent flow centrifugation, continuous flow centrifugation, and others. Application-wise, the apheresis market can be segmented into oncological diseases, immunological diseases, hematological diseases, cardiovascular diseases, renal diseases, neurological diseases, and others. Based on end-users, the apheresis market includes hospitals, blood banks, and others. Regional Analysis: Geographical analysis of the apheresis market includes the Americas, Europe, Asia Pacific (APAC), and Rest-of-the-World (RoW). Technological superiority, robust infrastructure, consumer-friendly healthcare insurance policy, and other factors are proving vital for the North America market growth. The market is further getting tractions from the research and development sector here the laboratories are promoting requirement for the system. At the same time, investments made by private and public sectors are chalking out good times for the market ahead. Europe assumes the second lead with similar features like that of the Americas to support the apheresis industry. It gets further help from ever-vigilant governments who take serious steps to advance the healthcare sector. This squarely impacts the apheresis market growth as well. The APAC region is expected to emerge as the fastest growing region during the forecast period. Several emerging economies are providing substantial backings to the healthcare sector to become a lucrative opportunity for the developed countries. Medical tourism is a factor that can provide thrust to the market. Browse Complete Report: https://www.marketresearchfuture.com/reports/apheresis-market-1508 Competitive Landscape: Significant contributions are getting made to the global apheresis market by Kaneka Corporation (Japan), Terumo BCT Inc. (US), Fresenius Medical Care (Germany), Nikkiso Co. Ltd. (Japan), Asahi Kasei Medical Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), HemaCare Corporation (US), Cerus Corporation (US), Haemonetics Corporation (US), Kawasumi Laboratories Inc. (Japan), Therakos, Inc. (U.S.), and others. In January 2018, MedAware Systems launched a database, backed by its SOHInfo division. The database includes cohort studies, clinical trials, medical journals, and others. MedAware Systems has launched the database with an aim to increase awareness regarding apheresis and provide all-round support. In July 2018, the U.S. FDA approved sodium citrate 4% w/v anticoagulant solution USP procedure during an automated apheresis procedure, a unique method initiated by Terumo BCT. Terumo BCT, a global leader in therapeutic apheresis, blood component, and cellular technologies, focused on the solution for mainly the shortage of sodium citrate that is impacting patients. Overview:
Renal dialysis is a process that work as an alternative for affected kidney. The process maintains a semblance in the body by ensuring proper disposal of waste, salt, and excess water from the body. This is necessary to keep a safe level of various chemicals like potassium, sodium and bicarbonate in the blood flow. The global Renal Dialysis Market is all set to surpass USD 26.6 billion valuation with a CAGR of 7.1% over the forecast period of 2017 to 2023. Market Research Future (MRFR) has a report on the market that claims factors of the market would trigger ample growth for the market. Factors impacting the global renal dialysis market includes hike in elderly population due to better treatment facilities, robust expenditure that the research development sector is receiving, better probability of expansion with the hike in the healthcare sector investment. Transforming reimbursement policies to suit specific needs of patients can also improve market growth. Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/1409 Segmentation: Market Research Future report on the renal dialysis market provides a comprehensive study of the renal dialysis market by setting a premise on the basis of types, product and end user. This segmentation has its focus on various factors that can impact the market in the coming years. By type, the renal dialysis market comprises primary and secondary dialysis. Primary dialysis study encompasses hemofiltration, peritoneal dialysis, and hemodialysis. Secondary dialysis includes intestinal dialysis and hemodiafiltration. By product, the renal dialysis market covers peritoneal dialysis products and hemodialysis products. The market is gaining ground by launching several new products in the hemodialysis products segment. The segment is expected to grab a higher market share in the foreseeable future. Based on the end user, the renal dialysis market centers around home care and hospital care. It often becomes impossible to move patients much and sometimes, patients prefer home care for various reasons owing to which the home care has the advantage in better permeation. Regional Analysis: On a region-specific scale MRFR studied the global renal dialysis market by integrating regions like North America, Europe, Asia Pacific (APAC), and Middle East Africa (MEA). The study has substantial scope to unravel region-specific details and optimize potential as per the demand. North America has better market reach and the region is finding superlative growth due to substantial inclusion of technologies and high expenditure capacity. The infrastructure of the regional healthcare sector is quite robust and is getting ample support from governments. The US and Canada are acting like crucial influencers. Europe and Asia Pacific are also witnessing hike in the market revenue but the APAC market would achieve better market rate due to high impact from its massive population. The number of people suffering from kidney-related diseases is quite high. The MEA market would record a steady growth in the coming years owing to lack of takers in the African region. It would profit more from the Middle East part. Browse Complete Toc :https://www.marketresearchfuture.com/reports/renal-dialysis-market-1409 Competitive Landscape: A lot of companies are taking a substantial interest in the global renal dialysis market that can favor the holistic market growth. The process involves a lot of impact on the strategic moves that considers merger, acquisition, branding, marketing, and other aspects. MRFR acknowledged contributions made by these companies and have profiled them for the better understanding of the market growth. These companies are Fresenius Medical Care (German), Baxter International Inc. (US), B.Braun Melsungen AG (Germany), DaVita Healthcare Partners Inc. (US), Nipro diagnostic Inc. (US), Medical Care AG Co., Gambro AB (Sweden), KGaA (Germany), Diaverum Deutschland GmbH (Germany), Nikkiso Co. Ltd. (Japan), Covidien (Ireland), NxStage Medical, Inc. (U.S.), Asahi Kasei Corporation (Japan), and others. In September 2019, Medtronic announced that their product IN.PACT Admiral DCB is showing favorable results in patients suffering from end-stage renal disease and who are having dialysis. Such a positive result would help it achieve FDA clearance Artificial Disc Replacement Market Size – Rising New Technologies Research Forecast to 202711/17/2021 The inability of individuals to maintain spine mobility successfully is estimated to stimulate the Artificial Disc Replacement Market. The medical device reports are made by Market Research Future, which includes market options for development. A 19.6 % CAGR is estimated to steer the global market in the upcoming period.
The dual influence of growing orthopedic surgeries and escalating geriatric population is predicted to create an impetus for the artificial disc replacement market share in the approaching period. The emphasis on research and development to develop efficient treatment methods is estimated to promote the growth of the artificial disc replacement market in the impending period. Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/1395 Segmental Analysis The segmental review of the artificial disc replacement market has been conducted on the basis of location, disc type, region, and material. Based on the disc type, the artificial disc replacement market has been segmented into elastic discs, composite discs, mechanical discs, and others. Based on the material, the artificial disc replacement market has been segmented into biopolymer, mixed, metal, and others. On the basis of region, the artificial disc replacement market is segmented into the Middle East, the Americas, Europe, Asia Pacific, and Africa. Detailed Regional Analysis The regional study of the artificial disc replacement market is segmented into the Middle East, the Americas, Europe, Asia Pacific, and Africa. The Americas artificial disc replacement market is expected to govern the market due to the secure healthcare sector, growing orthopedic surgeries, implementation of progressive technologies, and promising reimbursement policies. The European artificial disc replacement market is anticipated to be the second major regional market after the Americas region. The influences boosting the evolution of the artificial disc replacement market in this region are collective spending on healthcare, the collective geriatric population in this region, and promising government and regulatory strategies. The Asia Pacific artificial disc replacement market is anticipated to be the fastest mounting market for the duration of the forecast period due to the intensifying use of minimally invasive approaches, growing cases of degenerative disc complaints, and government advantage to deliver value healthcare services at low prices. The artificial disc replacement market in the Middle East African region is projected to be responsible for the minimum segment of the market owing to the small healthcare sector in the area, underprivileged financial condition, and deficiency of technical knowledge. Browse Complete Toc :https://www.marketresearchfuture.com/reports/artificial-disc-replacement-market-1395 Competitive Analysis The benefits of mergers and collaborations are likely to be more pronounced in this context as pooling in resources and capabilities can lead to the creation of a stronger competitive advantage for companies in the market. The tumultuous nature of global markets is currently estimated to create significant hindrances in the development of the market in the forecast period. The production technology and processes are estimated to undergo a considerable overhaul to be able to meet the expectations of the new reality in the business domains. The inducement provided by governments is estimated to create a positive outlook for the development of the market in the impending period. The market is estimated to be further motivated by the policies that will be framed to create a conducive working atmosphere in the coming period. The need for innovation and incorporation of more value in products is estimated to induce the global market constructively to expand in the forecast period. The eminent companies in the artificial disc replacement market are Medtronic, DePuy Spine, Zimmer Biomet, Stryker, Smith Nephew Plc, Alphatec Spine Inc., Aesculap Implant Systems, LLC, NuVasive, Inc., AxioMed LLC, Joimax GmbH, Globus Medical Inc., Orthofix Inc., and K2M Inc. North America, Europe to Dominate DPT Vaccine Market
The new research report from Market Research Future (MRFR) profiles the global DPT vaccine market in great detail and provides readers with a comprehensive overview of the market. The market’s historical growth trajectory, present conditions, and future growth prospects over the forecast period from 2016 to 2027 are studied in the report. The report provides a comprehensive overview of the market’s historical growth trajectory by detailing the historical stats regarding the market. Future projections are based on the detailed historical stats offered in the report. Based on this platform, future projections for the DPT vaccine market’s growth trajectory over the forecast period are provided in the report. The report also profiles the leading players in the global DPT vaccine market and gives readers a comprehensive analysis of the leading players in the global DPT vaccine market. The report also profiles the major drivers and restraints affecting the global DPT vaccine market. The factors making the market tick and those holding the market back are studied in detail in the report. The impact of the COVID-19 pandemic on the DPT vaccine market is also assessed in the report. DPT vaccine is a vaccine against diphtheria, pertussis, and tetanus, and serves as a three-in-one solution for bothersome diseases that have accounted for the lives of many children in the past. The increasing prevalence of pertussis among children, especially in developing countries in Africa, Asia Pacific, and South America, is likely to be a major driver for the global DPT vaccine market over the forecast period. Increasing awareness about the DPT vaccine is also likely to be a major driver for the global DPT vaccine market, as consumers are now coming forward to give DPT vaccines to their young children and are aware of the precise benefits of the vaccine. Increasing support from government agencies to widespread administration of the DPT vaccine is also likely to be a major driver for the DPT vaccine market over the forecast period. Request Free Sample: https://www.marketresearchfuture.com/sample_request/1357 Competitive Leaderboard: Leading players in the global DPT vaccine market include Chiron Pharmaceutical Pvt. Ltd., Wyeth, Lanzhou Institute of Biological Products, GSK, Sanofi, and Merck Co. Inc. Major players are likely to focus on production capacity expansion in the coming years, as the demand for DPT vaccines is likely to increase in the coming years. European companies hold a major share in the global DPT vaccine market. As a result, the European market for DPT vaccine is likely to emerge strongly on the global scene over the forecast period. Segmentation: The global DPT vaccine market is segmented on the basis of type, application, and region. By type, the global DPT vaccine market is segmented into DPaT, DTwP, and Tdap. All three segments hold a major share in the global DPT vaccine market and are likely to remain commercially relevant over the forecast period. By application, the global DPT vaccine market is segmented into diphtheria, pertussis, and tetanus. The growing prevalence of pertussis in children is likely to drive the pertussis segment of the global DPT vaccine market over the forecast period. The tetanus segment is also likely to exhibit steady growth over the forecast period. Browse Complete Report: https://www.marketresearchfuture.com/reports/dpt-vaccine-market-1357 Regional Analysis: North America holds the largest share in the global DPT vaccine market and is likely to remain the leading revenue generator over the forecast period. North American healthcare agencies, especially the agencies in the U.S. and Canada, are among the strongest and most comprehensive in the world. This has led to widespread incorporation of the DPT vaccine. This is likely to remain a major driver for the global DPT vaccine market over the forecast period. On the other hand, the increasing opposition to vaccination in the U.S. could have a retarding effect on the global DPT vaccine market. Europe is the second largest regional market for DPT vaccines, followed by Asia Pacific. European companies are in a strong position in the global DPT vaccine market, leading to strong growth of the DPT vaccine in the region. Market Highlights
Global Menopause Treatment Market is expected to have a market value of USD 15,456.3 Million by 2027. Menopause causes uncomfortable symptoms, such as hot flashes, vaginal dryness, and weight gain and menopause treatments such as hormonal and non-hormonal treatments help to relieve these symptoms. Over the years, major market players in the menopause treatment are focusing on various growth strategies such as product launches, product advancements and expansions to cater to the growing needs for patients seeking treatment for menopause symptoms. For instance, in April 2019, Otsuka Pharmaceutical launched EQUELLE, a non-prescription, non-hormonal supplement to alleviate the frequency of hot flashes and muscle aches associated with menopause in the US. Such strategies push the demand for branded as well as generic menopausal drugs, thus promising huge growth for the industry. Segment Analysis The global menopause treatment market is segmented based on treatment and distribution channel. The global menopause treatment market based on the treatment has been segmented into hormonal treatment and non-hormonal treatment. The hormonal treatment segment is further segmented into estrogen, progesterone, and combination. The non-hormonal treatment is further segmented into anti-depressants and others. Based on distribution channel, the menopause treatment market is segmented into hospital pharmacies, retail pharmacies, and online stores. Regional Analysis The global menopause treatment market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and Middle East & Africa. The Americas has been segmented into North America and Latin America, with the North America market further divided into the US and Canada. The Americas led the market and accounted for the largest share in 2019 owing to the increasing product approvals and high uptake of new technology. For instance, in July 2017, AMAG Pharmaceuticals, Inc. (US) launched Intrarosa (prasterone) for the treatment of moderate to severe dyspareunia a symptom of vulvar and vaginal atrophy (VVA), due to menopause. Thus, such strategies employed by major players aid in the increased growth rate for the Americas menopause treatment industry. The European menopause treatment market has been further segmented into Western Europe and Eastern Europe. The Western Europe menopause treatment market has further been classified into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. Europe follows the Americas in the global menopause treatment market. The increasing inclination of companies towards female technology (femtech) is boosting the growth of the menopause treatment market in European countries. Many digital health start-ups have identified this opportunity and are offering B2C digital health tools, such as mobile apps, to guide menopausal women through this phase with lifestyle intervention tips and online telehealth consultations. As a result, the region is expected to show significant growth in the menopause treatment market. The menopause treatment market in Asia-Pacific has been segmented into China, India, Japan, South Korea, Australia, and the rest of Asia-Pacific. Asia-Pacific is expected to register the highest growth rate over the forecast period from 2020 to 2027. This is owing to the growing penetration of the women’s health sector, increasing awareness about the betterment of the women’s health, and the growing number of educational campaigns related to the benefits of hormone replacement therapy in China, Japan, India, and Australia. The Middle East & Africa menopause treatment market is segmented Saudi Arabia, the United Arab Emirates (UAE), Oman, Kuwait, Qatar, and the rest of the Middle East & Africa. The negative connotation of menopause has resulted in a negative attitude towards menopause in premenopausal women. However, with the increasing awareness created by private companies, the scenario is expected to change in the next ten years. Browse Full Report Details @ https://www.marketresearchfuture.com/reports/menopause-treatment-market-4579 Key Players MRFR recognizes the following companies as the Key Players in the Global Menopause Treatment Market— Novo Nordisk A/S (Denmark), Pfizer Inc. (US), Allergan (Ireland), Eli Lily and Company (US), Emcure Pharmaceuticals Ltd (India), Novartis AG (Switzerland), Cipla Inc. (India), Teva Pharmaceuticals (Israel), Merck & Co., Inc. (US), Abbott Laboratories (US). Key Findings of the Study
FREE SAMPLE Market Research Future (MRFR) has published a cooked research report onthe “Global Eyelashes Enhancing Agents Market” that contains the information from 2018 to 2027.
The eyelashes enhancing agents market is expected to register a CAGR of 8.38%during the forecast period 2021-2027, to reach USD 541.33 million by 2027. MRFR recognizes the following companies as the key players in the global eyelashes enhancing agents market—Procter & Gamble (US),L'Oreal S.A (France),AbbVie Inc (US),The Estée Lauder Companies Inc.(US),Shiseido Company, Limited (Japan),Grande Cosmetics, LLC. (US),Athena Cosmetics, Inc (US),Skin Research Laboratories (US),Beauty Essentials LLC(US), andSkinGen International Inc (US). Market Highlights The global eyelashes enhancing agents market is expected to have a value ofUSD 541.33 million by 2027. Eyelash enhancing agents functions to support and improve the overall appearance of eyelashes. These agents enhance, conditions, moisturize, and strengthen the eyelashes. Several temporary options for lash-lengthening are available in the market, such as mascara and false eyelashes. There are also various eyelash serums available in stores that strengthen and grow tiny hairs. The growth of the global eyelashes enhancing agents market is driven by the increasing prevalence of eye inflammation such as madarosis and blepharitis, a shifting trend towards the natural eyelashes enhance agent.However, sideeffects and allergic reactions arelikely to restrain the market growth. Segment Analysis The global eyelashes enhancing agents marketis segmented into type,application, content, and region. The typesegment is further segmented into curling, lengthening, volumizing, others.The application segment is further sub-segmented into eyelashes, nourishing, and others. The content segment is further segmented into bimatoprost, lash-building serum, skincare ingredients, herbal remedy, isopropyl cloprostenate, enhancer serum, and others. Access full report @ https://www.marketresearchfuture.com/reports/eyelashes-enhancing-agents-market-4862 Regional Analysis The global eyelashes enhancing agents market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas account for the major share of the market owing to the presence of the leading market players, increasing awareness for eyelashes enhancing agents, and high healthcare expenditure. People in this region are more focused on aesthetic appearance that leads to an increase in spending. To improve the quality of products in the cosmetic industry, the demand for advanced and better eyelashes enhancing agents has increased. Moreover, an overdose of various anti-cancer drugs causes of loss of eyelashes. Europe is the second-largest market. Major driving factors for the market growth are the increasing prevalence of eye inflammations such as madarosis and blepharitis, the growing cosmetic industry, and well-developed technology. Additionally, increasing demand for cosmetic products such as eyelashes enhancing agents and risingadoption of new & unique fashion trends has provided fuel for the growth of the eyelashes enhancing agents market Asia-Pacific is the fastest-growing eyelashes enhancing agents market. The increasing need for better eyelashes enhancing agents, rapidly improving technology in the cosmetic industry, and a large target population drive the growth of this market in the Asia-Pacific region. Increasing healthcare expenditure, growing demand for eyelashes enhancing agents, and its increasing applications in repairing damaged eyelashes, have paved the way for market growth. Furthermore, the developing healthcare sector and increasing government support havefueled the market growth. The Middle East & Africa holds the least share in the market due toslow developing countries, especially Africa. The market is segmented into the UAE, Saudi Arabia, Oman, Kuwait, Qatar, and the Rest of the Middle East & Africa. In the Middle East & Africa, healthcare spending has increased during the last few years owing to increasing awareness about development in the healthcare sector. The major factorsdriving the growth of the Middle East & Africa eyelash enhancing agents market are the growing demand for eyelash enhancing agents and the increasing adoption of new & unique fashion trends. Key Findings of the Study
Market Highlights
Global Veterinary Medicine Market is likely to register a CAGR of 5.57% during the forecast period and expected to hit USD 42,985.42 Million by 2027. Like humans, animals are prone to various diseases caused by bacteria, parasites, fungi, and viruses. Veterinary medicine is one of the most effective ways to reduce the disease burden in farm animals and pets. Increasing zoonotic and chronic diseases among animals affect human interests widely. One of the main reasons for the growing number of chronic diseases is the increasing life expectancy of pets due to the developing healthcare facilities and good nutrition. The growing rates of pet ownership, rising chronic diseases, and increasing consumption of meat are anticipated to drive the growth of the global veterinary medicine market. Recently, in November 2018, Merck Animal Health launched new vaccine INNOVAX-ND-IBD in the US. This vaccine is mainly used for treatment of highly infectious diseases such as infectious bursal disease and new castle disease. Moreover, in July 2019, Vetoquinol S.A. announced a plan to reorganize its production facilities in Europe. Under the agreement, the company will hand over the production of the Ascor range, currently manufactured at the Vetoquinol Italia plant in Emilia-Romagna, to pharmaceutical facilities in Europe. The Ascor range includes veterinary drugs and non-medicinal products primarily designed for pig and poultry farmers. Segment Analysis Global Veterinary Medicine Market has been divided based on Animal Type, Product, Route of Administration, and Distribution Channel. The market, based on animal type, has been segregated into domesticated and companion. Based on product, the global veterinary medicine market is segmented into drugs and vaccines. The global veterinary medicine market, on the basis of route of administration, has been segmented into oral, parental, and others. On the basis of distribution channel, the market is bifurcated into veterinary hospitals & clinics, retail stores, and online pharmacies. Regional Analysis Global Veterinary Medicine Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and Middle East & Africa. The Americas is likely to hold the largest share of the global veterinary medicine market during the assessment period owing to the rise in companion animal ownership and growing prevalence of animal diseases in the region. The Europe market is expected to register a substantial growth in the market owing to the rising prevalence of diseases, new product approvals, and presence of developed veterinary healthcare infrastructure. Asia-Pacific is estimated to be the fastest-growing regional market due to the growing penetration of the veterinary sector, surge in the number of private veterinary clinics, increasing awareness about animal welfare, and government campaigns for the welfare of pet animals in China, Japan, India, South Korea, and Australia. The veterinary medicine market in Middle East & Africa is expected to witness gradual growth owing to the presence of low-income countries in the region. Access Report Details @ https://www.marketresearchfuture.com/reports/veterinary-medicine-market-844 Key Players MRFR recognizes the following companies as the Key Players in the global Veterinary Medicine Market-- Boehringer Ingelheim, Ceva, Chanelle Pharma Group, Dechra Pharmaceuticals plc, Elanco, Merck Animal Health, Norbrook Laboratories, Vetoquinol S.A., Bayer AG, and Zoetis. Key Findings of the Study
North American Dental Equipment Market - Overview
Over the last two hundred years, dentistry has made countless strides and also experienced a few setbacks globally. Though, the ultimate goal of the profession has always remained the same, which is to meet the treatment needs of the patient. Dental technology remains an important and valuable key to providing excellence in patient care. The role of today’s dental specialist has extended and evolved to being a gatekeeper of new product information, advisor on new restorative materials, imaging devices and radiology techniques, advocate of new technologies to improve consistency and accuracy, and educator for improved chair side techniques. At the same time, the industry endures to wrestle with new challenges redesigning the profession of dentistry. In a dental market where fewer percentage of educated and experienced dentists must meet the needs of an ever-growing population, new technologies arose to increase production levels and awaken a dental technology workforce. Dental Laboratories face many challenges today like productivity, profitability, staying competitive, new technologies, and offshore competition. However, it is suggested that the profession has contended with and seized many of these same issues over the recent years. Dental equipment’s are used for diagnosis and treatment of dental problems with the help of X-rays, radioactive substances, and other forms of radiant energy. The market is majorly driven by the technological advancements in the dental equipment, high adoption of digital dental radiology and imaging systems, growth in aging population, and dental surgeries gaining impetus. However, huge demand for dental tourism and use of refurbished dental instruments is expected to restrain the growth of this market. The North American dental equipment market is growing at a sound pace and is expected to grow at a CAGR of 6.23% during the forecast period 2017-2023. According to a recent study report published by the Market Research Future, the North America Dental Equipment market is expected to gain eminence over the forecast period. The market is forecasted to demonstrate a steady growth by 2023, surpassing its previous growth records in terms of value with a constant CAGR during the anticipated period (2017–2023). North American Dental Equipment Market - Competitive Analysis Patterson Dental (US), Henry Schein (US), Dentsply Sirona (US), 3M (US), Straumann (Switzerland), Danaher Corporation (Switzerland), PLANMECA OY (Finland), Carestream Health, Inc.(U.S.), and Biolase Inc. (U.S.) and others are some of the prominent players at the forefront of competition in the North America Dental Equipment Market and are profiled in MRFR Analysis. The market for dental equipment is characterised by the presence of several well-established and small players, the global market of dental equipment appears to be highly competitive and fragmented. Major players are increasingly expanding their footprint in the emerging nations, making it putting pressure on the regional players, especially in terms of features such as type, product portfolios, and pricing. The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The key players in the industry are adopting to compete with one another directly and indirectly with other ecosystem players. To craft a reasonable impact in the market the companies are getting into various key activities. Out of product launches, partnerships & collaborations, and acquisitions are some of the major strategies adopted by the key players in this market. For instance, in May 2017; Dentsply Sirona Endodontics announced X-Smart IQ digital endodontics ecosystem and app. The system, complete digital ecosystem, redefines the endo experience at every stage of the procedure. The X-Smart IQ iOS app creates customizable treatment plans based on dental professionals’ preferred techniques. In addition, the app allows synchronization of future products and immediate updates, allowing the technology to grow with the dentist’s practice. Furthermore, September 2016, 3M acquired Semfinder, a leading developer of precise semantic coding of medical services. The acquisition of Semfinder provides important new coding technology that will enable 3M to accelerate the availability of its 3M 360 Encompass System in countries adopting electronic medical records. In August 2016, Henry Schein announced acquisition of 80% ownership of Marrodent, which is a full service dental distributer of Poland, thus marking Henry Schein’s entry into the dental market of Poland. In April 2017, 3M Oral Care launches Filtek One bulk-fill restorative with one step placement. 3M Oral Care has launched 3M Filtek One, a bulk-fill restorative material designed for one-step placement without compromising esthetics. Bulk fill composites have become popular in recent years because of their simplicity and speed; and are faster, easier. Browse Full Report @ https://www.marketresearchfuture.com/reports/north-american-dental-equipment-market-4625 EHR-EMR Market Insights
The growth of healthcare IT and its immense potential in consolidating data as well its ability to drastically increase efficiency has impacted the global & US EHR-EMR market to a great extent. Market Research Future has released its report on the global US EHR-EMR market which includes various intelligent insights as well a collection of highly relevant facts and figures with regards to the future of the market for the review period from 2018 to 2027. According to findings of the analysis carried out by MRFR, the global & US EHR-EMR market is expected to register a CAGR of 5.82% during the review period which is likely to result in a market value of USD 42,427.27 Mn by the end of 2027. EHRs & EMRs help avoid medical errors which are often encountered during the diagnosis and treatment process due to the lack of awareness on the part of medical professionals regarding medical history and therapeutic guidelines specific to the patient. Moreover, reportedly, clinical decisions made using the assistance of EHRs have increased the efficiency of care. These clinical benefits are significant in their positive impact on the global & US EHR-EMR market. Increasing government support of EHRs have also been a strong driving factor for the adoption of EHRs & EMRs as well as the subsequent growth of the global market. Prime examples include the NHS which has implemented the Integrated Digital Care Fund to support the shift from paper-based health records to integrated digital care records. These types of supportive, and encouraging government initiatives are expected to compel market growth over the review period. Despite these positive impacts, the market is challenged by the task of training medical professionals in proficiency in EHR administration. Moreover, the high costs of implementation are discouraging of market growth. In 2014, according to the Office of the National Coordinator for Health Information Technology estimated the costs of deploying EHRs between the range of USD 15,000 and USD 70,000 per provider. However, developing countries in the Asia Pacific region are untapped markets with considerable promise. Growing digitization of the healthcare infrastructure in a rapidly urbanizing region is expected to offer several avenues for the growth of the market. Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/global-EHR-EMR-market-775 Market Segmentation Components of EHR & EMR have been segmented into software, services & consulting, and hardware. The software segment has captured a 59.1% share of the market and is also projected to expand at the highest growth rate during the assessment period. Applications of EHR & EMR are largely divided between the specialty based segment and general based segment. The specialty based segment is further sub-segmented to include neurology, oncology, radiology, cardiology, and others. The specialty based segment has not only captured the largest share of the global & US EHR-EMR market but is also anticipated to expand at the fastest pace at a CAGR of 6.02% during the review period. The rapid growth of the specialty-based segment is due to the increasing incidences of cardiovascular diseases as well as a high prevalence of chronic diseases. Mode of delivery of EHR and EMR has been segmented into cloud-based, and on-premise model. The on-premise segment is the most significant segment in the global market. However, the rapid growth of the cloud-based segment is expected to bring both segments nearly at par by the end of 2027. End-users of EHRs and EMRs have been segmented into ambulatory care, diagnostic centers, hospitals & clinics, and others. Hospitals & clinics are the dominant segments in the global & US EHR-EMR market due to the increasing adoption of healthcare IT in this segment. However, the ambulatory segment is growing at the most rapid pace due to the demand for instant data retrieval in emergency healthcare situations. Regional Analysis MRFR's coverage of the global market scenario covers key regions such as the Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas have the dominant share of the global & US EHR-EMR market. The North American segment of the market which includes the US has a strong presence of several market leaders as well as a thriving healthcare sector. The well-developed healthcare sector in the region has an affinity toward the adoption of advanced IT technology. Growing investments in healthcare and increasing demand for advanced healthcare. IT is likely to lead the market to grow over the review period. Meanwhile, the Asia Pacific market is on track to grow at the most significant CAGR of 6.77%. Japan is the largest country-level market. Other important country level markets include India, China, and Austrailia. The rapid digitization of the regions healthcare segment, combined with the healthcare reforms taking place are expected to drive the APAC's growth over the review period. Increasing awareness regarding electronic health records, a rising geriatric population as well as the presence of a significant and growing patient pool is expected to influence the EHR-EMR market positively. Key Players Market Research Future has tracked the competition in the global & US EHR-EMR market and analyzed the various growth strategies used by leading market players. Market players of prominence included in the report are Allscripts Healthcare Solutions, Athenahealth Inc., Agastha Inc, Cerner Corporation, Epic Systems, eClinicalWorks, Advanced MD Inc, Advanced Data Systems Corporation, GE Healthcare, Medical Information Technology Inc., Koninklijke Philips N.V., and Meddbase (Medical Management Systems Ltd). |
|